A randomized trial of pegylated recombinant human granulocyte-colony stimulating factor to prevent febrile neutropenia in breast cancer after chemotherapy.

被引：0
|
作者：
Zhang, Lina
Li, Yuntao
Fan, Zhonglin
Wang, Meiqi
Hui, Tianli
Zhang, Yanshou
Gao, Chunhui
Zhang, Jing
Zhang, Guoshuan
Kong, Xiangshun
Geng, Cuizhi
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
[2] Baoding First Cent Hosp, Baoding, Peoples R China
[3] Hebei Gen Hosp, Dept Glandular Surg, Shijiazhuang, Peoples R China
[4] Shijiazhuang Peoples Hosp, Shijiazhuang, Peoples R China
[5] Xingtai Peoples Hosp, Xingtai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12516
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prophylaxis of Febrile Neutropenia with granulocyte-colony stimulating factor
    Takamatsu, Yasushi
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 59 - 59
  • [2] A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens
    Zardawi, Sarah J.
    Nordman, Ina
    Zdenkowski, Nicholas
    [J]. CANCER REPORTS, 2020, 3 (05)
  • [3] Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer
    Weiwei Huang
    Jian Liu
    Yi Zeng
    Fan Wu
    Nani Li
    Kan Chen
    Yi Hong
    LiLi Wang
    Hongyu Zhen
    Lin Lin
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 82 : 607 - 613
  • [4] Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer
    Huang, Weiwei
    Liu, Jian
    Zeng, Yi
    Wu, Fan
    Li, Nani
    Chen, Kan
    Hong, Yi
    Wang, LiLi
    Zhen, Hongyu
    Lin, Lin
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 607 - 613
  • [5] Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients
    Ashrafi, Farzaneh
    Salmasi, Mehrzad
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2018, 23
  • [6] Impact of granulocyte-colony stimulating factor on docetaxel-induced febrile neutropenia in patients with breast cancer
    Zekri, Jamal
    Nawaz, Azhar
    Rasool, Haleem
    Ahmad, Imran
    Abdel Rahman, Hossam
    Dada, Reyad
    Abdelghany, Ehab Mosaad
    Farag, Kamel
    Ibrahim, Refaei Belal
    Deibas, Mohamed Youssef
    Kamel, Mohamed Kamal
    Allithy, Ahmed
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1681 - 1686
  • [7] A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor (GCSF) on febrile neutropenia (FN) rates in (neo)adjuvant breast cancer chemotherapy regimens
    Zardawi, Sarah
    Zdenkowski, Nicholas
    Nordman, Ina
    Mallesara, Girish
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 190 - 191
  • [8] A retrospective observational study on the efficacy and safety of pegylated recombinant human granulocyte-colony stimulating factor and recombinant human granulocyte-colony stimulating factor in patients with lymphoma.
    Liu, Lihong
    Wu, Lili
    Huang, Chen
    Zhao, Guimin
    Ma, Guangyu
    Gao, Yuhuan
    Diao, Lanping
    Yao, Yingzhen
    Wu, Xiaolin
    Gao, Zhe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] A prospective, randomized clinical trial of emergency treatment of chemotherapy-induced neutropenia and febrile neutropenia by pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF)
    Huang, Xiaofeng
    Li, Shuo
    Shi, Wenjie
    Wang, Ye
    Wan, Xinyu
    He, Jinzhi
    Xu, Yinggang
    Zhang, Weiwei
    Shi, Xiaoqing
    Chen, Rui
    Xu, Lu
    Zha, Xiaoming
    Wang, Jue
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 372 - 379
  • [10] Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
    Chris Skedgel
    Daniel Rayson
    Tallal Younis
    [J]. Supportive Care in Cancer, 2016, 24 : 387 - 394
12345